Practice question

Macroculture denotes large-scale culture formats including T-75 and T-175 flasks, roller bottles, multi-tray CellSTACKs and Cell Factories, and stirred-tank bioreactors producing volumes from hundreds of milliliters to thousands of liters. Preferred when substantial cell biomass required for downstream processing such as purification of therapeutic recombinant proteins like erythropoietin, monoclonal antibodies from CHO cells, viral vectors for gene therapy, vaccine virus harvest from Vero, or preparation of whole cell lysates for proteomics and metabolomics. Macro scale enables control over dissolved oxygen via sparging, pH via base addition, nutrient feeding strategies including fed-batch, and perfusion cultures maintaining constant environment. When objective is single-cell RNA sequencing or rare cell characterization, microculture or specialized microfluidic devices better preserve heterogeneity. High throughput screening also favors miniaturization. Choosing macroculture involves balancing cost of medium, risk of contamination leading to loss of large batch, and compliance with Good Manufacturing Practice for clinical products. Process analytical technology monitors glucose and lactate guiding feeding strategies in macroculture bioprocesses. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.